By contrast, M1 macrophages, though less well classified and capable of subtype interconversion, dominate early tumor stages, releasing TNF-α, CXCL9, CXCL10, iNOS, and ROS to induce inflammation and eliminate tumor cells (48–51). Here, CXCL9 is linked to neoplasm.